Clinical Trial Update: Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Abraxane plus FEC chemotherapy for breast cancer has completed; the snippet does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Abraxane (paclitaxel albumin-bound)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (Ellence) (epirubicin)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED